Osprey Point Nursing Center

In the surveyor’s words

From the most serious findings on record at Osprey Point Nursing Center, in the surveyor’s own words.

• No harm, potential for more than minimal, patternF684Nov 30, 2023

  Based on observation, interview, and record review the facility failed to provide treatment and care in accordance with professional standards of practice for 2 of 3 residents reviewed for intravenous infusion and wound care (Resident #48 and #35). Findings include: 1. During an observation on 11/28/23 at 7:45 AM of Resident #48's peripherally inserted central catheter (PICC) line dressing revealed was not dated, there was no gauze or bio-patch, and the stabilizer is observed outside of the transparent dressing. The PICC line had residue, there was a kink in the catheter and the insertion site had bloody leakage (photographic evidence). During an interview on 11/28/23 at 7:45 AM, Resident #48 stated My PICC line has been in since October 21st; I finished my antibiotics yesterday. […]

• No harm, potential for more than minimal, isolatedF689Jul 16, 2026

  Based on observation, interview, and record review the facility failed to ensure smoking paraphernalia (lighter) was secured to prevent possible accidents for 1 of 3 residents, Resident #34, sampled residents who smoke. Findings include: During an observation on 7/13/2026 at 9:55 AM, an unsecured yellow lighter was observed on Resident #34's bedside table. Resident #34 was not in the room, the lighter was not secured and was accessible to others. During an interview on 7/13/2026 at 9:57 AM, the Administrator stated, I'm not even sure where she [Resident #34] got that from. Lighters are supposed to be kept in the smoking box because they [facility residents] go out [to smoke] at specific times. […]

• No harm, potential for more than minimal, isolatedF695Jul 16, 2026

  Based on record review, observation, and interview, the facility failed to ensure physician ordered oxygen administration was followed for 1 of 3 residents, Resident #22, sampled for oxygen administration. Findings include: During an observation on 07/13/2026 at 9:22 AM, Resident #22 was administered oxygen via nasal cannula by an oxygen concentrator at 2 liters per minute. (Photographic evidence obtained) During an observation on 7/14/2026 at 8:18 AM, Resident #22 was administered oxygen via nasal cannula by an oxygen concentrator at 2 liters per minute. […]

• No harm, potential for more than minimal, isolatedF761Jul 16, 2026

  Based on observation, interview, and record review, the facility failed to ensure medications were properly stored when unattended for residents located on 2 of 3 halls, Residents #17, #26, #49, and #50. Findings included:1) During an observation on 7/13/2026 at 09:02 AM of Resident #17's room, one Fluticasone-Salmeterol 250-50 mcg/act (micrograms per inhalation) aerosol powder, breath activated inhaler was observed lying on the bedside table unsecured.During an observation on 7/14/2026 at 9:10 AM of Resident #17's room, one Fluticasone-Salmeterol 250-50 mcg/act aerosol powder, breath activated inhaler was observed lying on the bedside table unsecured.During an interview on 7/14/2026 at 09:30 AM Staff A, License Practical Nurse (LPN) stated, That inhaler must have been left by the night… […]

• No harm, potential for more than minimal, isolatedF880Jul 16, 2026

  Based on observation, record review, and interview, the facility failed to prevent the possible spread of infection for medication-related equipment maintenance, medication administration, wound care, and respiratory equipment maintenance. Findings included:1) Review of the medical record for Resident #49 documented the resident was admitted on [DATE] with medical diagnosis to include atrial fibrillation (afib - irregular heartbeat) and hypertension (high blood pressure).Review of physician orders for Resident #49 documented, Apixaban [blood thinner] 2.5 mg [milligrams] - give 1 tablet by mouth two times a day for afib, Empagliflozin [used to treat heart failure (HF)] 10 mg - give 1 tablet by mouth one time a day for HF, Metoprolol Succinate ER [extended release - used to treat high blood… […]